Caroline Young, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 168 shares at $3.50 ($578) on 2025-07-31, disclosed to the SEC on 2025-08-11.
Scheduled purchase ($578) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.56 | 8 | $28 | 4.9% |
| 2 | $3.52 | 8 | $28 | 4.9% |
| 3 | $3.53 | 8 | $28 | 4.9% |
| 4 | $3.23 | 8 | $26 | 4.5% |
| 5 | $3.06 | 8 | $24 | 4.2% |
| 6 | $3.05 | 8 |
| $24 |
| 4.2% |
| 7 | $3.20 | 8 | $26 | 4.4% |
| 8 | $3.21 | 8 | $26 | 4.4% |
| 9 | $3.46 | 8 | $28 | 4.8% |
| 10 | $3.45 | 8 | $28 | 4.8% |
| 11 | $3.79 | 8 | $30 | 5.2% |
| 12 | $3.82 | 8 | $31 | 5.3% |
| 13 | $3.59 | 8 | $29 | 5.0% |
| 14 | $3.45 | 8 | $28 | 4.8% |
| 15 | $3.47 | 8 | $28 | 4.8% |
| 16 | $3.54 | 8 | $28 | 4.9% |
| 17 | $3.55 | 8 | $28 | 4.9% |
| 18 | $3.37 | 8 | $27 | 4.7% |
| 19 | $3.47 | 6 | $21 | 3.6% |
| 20 | $3.33 | 6 | $20 | 3.5% |
| 21 | $3.55 | 6 | $21 | 3.7% |
| 22 | $3.50 | 6 | $21 | 3.6% |
| Total | $3.44 avg | 168 | $578 | 100% |
| Filing → |
| CPIX | BUY | 2025-06-06 | $429 | — | Filing → |
| CPIX | BUY | 2025-05-09 | $417 | — | Filing → |
| CPIX | BUY | 2025-04-04 | $384 | — | Filing → |